US Gov Invests Billions in Biotech Future: You Need to Know!
17 Jul 2026 · 0 min

0:28
In this segment, Stacy L. Chin emphasizes that biomanufacturing and synthetic biology are critical next steps because scientific discoveries are futile without scalable production. She explains that the U.S. government plans to invest billions of dollars into building a robust biotech supply chain—including mRNA manufacturing, CRISPR delivery systems, and bio‑based material production—because constructing such large‑scale facilities is capital‑intensive and risky for private investors. Consequently, federal funding is stepping in to de‑risk and accelerate the development of these essential manufacturing capabilities.










